4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-20-023248
Corporate Executive VP & CFO sold 3,304 shares at an average $216.54 ($715,444)
- Corporate Executive VP & CFO acquired 3,304 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Smith David Ross · Corporate Executive VP & CFO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-08-07 | Exercise or conversion : show line 1 in the form | +3,304 | $144.67 | $477,990 | 24,071 | D |
| 2020-08-07 | Sale : show line 2 in the form | −2,297 | $216.42 | $497,110 | 21,774 | D |
| 2020-08-07 | Sale : show line 3 in the form | −1,007 | $216.82 | $218,334 | 20,767 | D |
| Open-market sales · 3,304 sh · avg $216.54 · $715,444 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-08-07 | Exercise or conversion : show line 4 in the form Stock Options (Right to Buy) | −3,304 | 9,914 | D |
Loading xslF345X03/form4.xml…